Definition of the Clinical Antibacterial Spectrum of Activity

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

K. Kümmerer, A. Henninger Clinical Microbiology and Infection

Approach to diagnosis of infective endocarditis

P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys

Herpes zoster in non-hospitalized children

Antimicrobial Activity of SCH 27899, Oligosaccharide Member of the Everninomycin Class with a Wide Gram-Positive Spectrum Ronald N. Jones, M.D., Mary.

K. Kümmerer, A. Henninger Clinical Microbiology and Infection

Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995 Thomas Lund S⊘rensen, Niels Frimodt-M⊘ller,

Hydatid disease Clinical Microbiology and Infection

Didier Guillemot, Claude Carbon Clinical Microbiology and Infection

Current patterns and evolution of antibiotic resistance among bacterial pathogens involved in acute otitis media Fernando Baquero, Rafael Cantón, Fernando.

Link between intracellular pathogens and cardiovascular diseases

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species Jacques Dubois, Claude St-Pierre Clinical.

Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente

A. Bryskier Clinical Microbiology and Infection

Structure of grepafloxacin relative to activity and safety profile

Vector control: a cornerstone in the malaria elimination campaign

The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci Keith Klugman, Fred Goldstein,

Fourth-generation cephalosporins: a review of in vitro activity, pharmacokinetics, pharmacodynamics and clinical utility Javier Garau, Walter Wilson,

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Sofie Arens, Jan Verhaegen, Ludo Verbist

Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.

Training for the infectious diseases speciality in Norway

Epidemiology of opportunistic infections in AIDS patients

Laboratory diagnosis and biosafety issues of biological warfare agents

Sepsis and neutropenia induced by clozapine

C. -J. Soussy, J. Nguyen, F. Goldstein, H. Dabernat, A. Andremont, R

A comparative study of the in vitro activity of meropenem and representatives of the major classes of broad-spectrum antibiotics J. Moira Greenhalgh,

Uncommon opportunistic fungi: new nosocomial threats

André Bryskier Clinical Microbiology and Infection

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens* M. Kanellopoulou, A. Makri,

Laboratory diagnosis of Clostridium difficile disease

Jacques Sirot, Patrice Courvalin, Claude-James Soussy

Antimicrobial susceptibility of non-Bacteroides fragilis group anaerobic Gram-negative bacilli in Europe Anna King, Julie Downes, Carl-Erik Nord, Ian.

Recent developments in staphylococcal scalded skin syndrome

S8 – S47 and O50 – O440 Clinical Microbiology and Infection

A. Bryskier Clinical Microbiology and Infection

A. Bryskier Clinical Microbiology and Infection

Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union S. Bronzwaer Clinical.

Community-acquired pneumonia: epidemiologic and clinical consideration

Comparative antimicrobial spectrum and activity of the desfluoroquinolone BMS (T-3811) tested against non-fermentative Gram-negative bacilli W.

Comparison of two agar dilution methods and three agar diffusion methods, including the Etest, for antibiotic susceptibility testing of thermophilic Campylobacter.

Clinical infection services—the Leiden experience

Ethan Rubinstein, Itzhak Levy Clinical Microbiology and Infection

Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party Dilip Nathwani, Christopher Conlon Clinical.

Clinical Microbiology and Infection

Clinical Microbiology and Infection

W. Eugene Sanders, Christine C. Sanders

Overview of cefixime use in community-acquired infections

Brita Bruun, Henrik Westh, Jørgen Stenderup

Sanford Chodosh Clinical Microbiology and Infection

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

New oral cephalosporins in pediatric community-acquired infections

In vitro activity of evernimicin and selected antibiotics against methicillin-resistant staphylococci: a 24-country study R. Goering, C.-E. Nord, R.

Modification of prescribers’ behavior: the Icelandic approach

Carratalà J. Clinical Microbiology and Infection

In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species† C.B. Moore,

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands J.W. Mouton, A.R. Jansz Clinical.

Impact of antibiotic restrictions: the patient's perspective

Decision-making in otitis media in children, Part I: epidemiologic data and definitions for a reliable cost-effectiveness analysis Bernard Grenier Clinical.

Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party Dilip Nathwani, Christopher Conlon Clinical.

The future of diagnostic bacteriology

Presentation transcript:

Definition of the Clinical Antibacterial Spectrum of Activity Fred Goldstein, Claude-James Soussy, André Thabaut Clinical Microbiology and Infection Volume 2, Pages S40-S45 (December 1996) DOI: 10.1111/j.1469-0691.1996.tb00874.x Copyright © 1996 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 MIC distributions: (a, b), unimodal distribution; (c), bimodal distribution; (d), multimodal distribution. Clinical Microbiology and Infection 1996 2, S40-S45DOI: (10.1111/j.1469-0691.1996.tb00874.x) Copyright © 1996 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Classification of species in the antibacterial spectrum of activity of an antibiotic: (a), usually susceptible species; (b), resistant species; (c), moderately susceptible species; (d), non-constantly susceptible species, c =low breakpoint or susceptibility breakpoint; C = high breakpoint or resistance breakpoint. Clinical Microbiology and Infection 1996 2, S40-S45DOI: (10.1111/j.1469-0691.1996.tb00874.x) Copyright © 1996 European Society of Clinical Infectious Diseases Terms and Conditions